Technical approaches for mouse models of human disease

The mouse is the leading organism for disease research. A rich resource of genetic variation occurs naturally in inbred and special strains owing to spontaneous mutations. However, one can also obtain desired gene mutations by using the following processes: targeted mutations that eliminate function in the whole organism or in a specific tissue; forward genetic screens using chemicals or transposons; or the introduction of exogenous transgenes as DNAs, bacterial artificial chromosomes (BACs) or reporter constructs. The mouse is the only mammal that provides such a rich resource of genetic diversity coupled with the potential for extensive genome manipulation, and is therefore a powerful application for modeling human disease. This poster review outlines the major genome manipulations available in the mouse that are used to understand human disease: natural variation, reverse genetics, forward genetics, transgenics and transposons. Each of these applications will be essential for understanding the diversity that is being discovered within the human population.

[1]  Bin Liu,et al.  Functional genetic analysis of mouse chromosome 11 , 2003, Nature.

[2]  David A Largaespada,et al.  Transposons for cancer gene discovery: Sleeping Beauty and beyond , 2007, Genome Biology.

[3]  M. Evans,et al.  Gene trapping and functional genomics. , 1997, Trends in genetics : TIG.

[4]  Miriam Scadeng,et al.  Development of a novel mouse glioma model using lentiviral vectors , 2009, Nature Medicine.

[5]  T. Bestor.  Transposons Reanimated in Mice , 2005, Cell.

[6]  M. Justice.  Capitalizing on large-scale mouse mutagenesis screens , 2000, Nature Reviews Genetics.

[7]  M. Angelis,et al.  Large scale ENU screens in the mouse: genetics meets genomics. , 1998, Mutation research.

[8]  P. Hunsicker,et al.  Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Martin S. Taylor,et al.  Genome-wide genetic association of complex traits in heterogeneous stock mice , 2006, Nature Genetics.

[10]  T. Dechiara.  Gene targeting in ES cells. , 2001, Methods in molecular biology.

[11]  M. Capecchi.  The new mouse genetics: altering the genome by gene targeting. , 1989, Trends in genetics : TIG.

[12]  J. Nadeau.  Modifier genes and protective alleles in humans and mice. , 2003, Current opinion in genetics & development.

[13]  W. Alexander,et al.  Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Takeda,et al.  Functional genomics in the mouse using the sleeping beauty transposon system. , 2010, Methods in enzymology.

[15]  Michael G. Rosenfeld,et al.  Dramatic growth of mice that develop from eggs microinjected with metallothionein–growth hormone fusion genes , 1982, Nature.

[16]  A. Bradley,et al.  Agouti C57BL/6N embryonic stem cells for mouse genetic resources , 2009, Nature Methods.

[17]  Philippe Soriano,et al.  Widespread recombinase expression using FLPeR (Flipper) mice , 2000, Genesis.

[18]  B. Beutler,et al.  Precis on forward genetics in mice , 2007, Nature Immunology.

[19]  N. Crawford,et al.  The future of mouse QTL mapping to diagnose disease in mice in the age of whole-genome association studies. , 2008, Annual review of genetics.

[20]  P. Demoly,et al.  [Transgenic mice]. , 1992, Annales de dermatologie et de venereologie.

[21]  J. Guénet.  Chemical mutagenesis of the mouse genome: an overview , 2004, Genetica.

[22]  M. Justice,et al.  Efficient generation and mapping of recessive developmental mutations using ENU mutagenesis , 2002, Nature Genetics.

[23]  K. Davies,et al.  Comparative genetic analysis: the utility of mouse genetic systems for studying human monogenic disease , 2007, Mammalian Genome.

[24]  A. F. Stewart,et al.  Engineering embryonic stem cells with recombinase systems. , 2006, Methods in enzymology.

[25]  Stefan Glaser,et al.  Current issues in mouse genome engineering , 2005, Nature Genetics.

[26]  L. Havekes,et al.  Local Cre-Mediated Gene Recombination in Vascular Smooth Muscle Cells in Mice , 2006, Transgenic research.

[27]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[28]  A. Kasarskis,et al.  A phenotype-based screen for embryonic lethal mutations in the mouse. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Steve D. M. Brown,et al.  A gene-driven approach to the identification of ENU mutants in the mouse , 2002, Nature Genetics.

[30]  C. Branda,et al.  Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. , 2004, Developmental cell.

[31]  Yueming Ding,et al.  A customized and versatile high-density genotyping array for the mouse , 2009, Nature Methods.

[32]  Nengjun Yi,et al.  The Collaborative Cross, a community resource for the genetic analysis of complex traits , 2004, Nature Genetics.

[33]  Lee M. Silver,et al.  Mouse Genetics: Concepts and Applications , 1995 .

[34]  D. Beier,et al.  Using ENU mutagenesis for phenotype-driven analysis of the mouse. , 2010, Methods in enzymology.

[35]  Wei Wang,et al.  The polymorphism architecture of mouse genetic resources elucidated using genome-wide resequencing data: implications for QTL discovery and systems genetics , 2007, Mammalian Genome.

[36]  A. Plagge.  Directed mutagenesis in embryonic stem cells , 2000 .